Vermont · 2025-2026 Regular Session · Bill
H 859: An act relating to psychedelic therapy and clinical drug development trials
Introduced Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
H 859 is a bill introduced in the Vermont House on February 3, 2026. According to its official title, it concerns: An act relating to psychedelic therapy and clinical drug development trials. Primary sponsor: Brian Cina (Democratic/Progressive), Conor Casey (Democratic), Troy Headrick (Independent), Bram Kleppner (Democratic), Kate Logan (Democratic), Jubilee McGill (Democratic). Most recent recorded action (February 3, 2026): Read first time and referred to the Committee on Health Care.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Sponsors
Sponsors by party (alphabetical): Democratic 4 · Democratic/Progressive 1 · Independent 1
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Brian Cina | Primary sponsor | Democratic/Progressive | House | Chittenden-15 |
| Conor Casey | Primary sponsor | Democratic | House | Washington-4 |
| Troy Headrick | Primary sponsor | Independent | House | Chittenden-15 |
| Bram Kleppner | Primary sponsor | Democratic | House | Chittenden-13 |
| Kate Logan | Primary sponsor | Democratic | House | Chittenden-16 |
| Jubilee McGill | Primary sponsor | Democratic | House | Addison-5 |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- Read first time and referred to the Committee on Health Care